Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
| Product: | ADT Booster |
| Active Ingredients: | Diphtheria toxoid, adsorbed 2IU Tetanus toxoid, adsorbed 20IU |
| Dosage Form: | Suspension for injection |
| New Zealand Sponsor: | Seqirus (NZ) Limited |
| Manufacturer: | AJ Vaccines A/S, Copenhagen, Denmark |
| Product: | NeutraFluor 5000 Sensitive |
| Active Ingredients: | Potassium nitrate 5%w/w Sodium fluoride 1.105%w/w equivalent to fluoride 5000ppm |
| Dosage Form: | Toothpaste |
| New Zealand Sponsor: | Colgate-Palmolive Limited (NZ) |
| Manufacturer: | Colgate-Palmolive Company, Tennessee, United States of America |
| Product: | Rapifen |
| Active Ingredient: | Alfentanil hydrochloride 0.5435mg/mL equivalent to alfentanil 0.5mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Seed Pharma Limited |
| Manufacturers: | Janssen Pharmaceutica NV, Beerse, Belgium GlaxoSmithKline Manufacturing SpA, Parma, Italy |
Dated this 28th day of August 2020.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).